Federal Supply Schedule 36F79724D0177
Award Date
8/15/24
Last Date to Order
8/14/29
Federal Agency
Veterans Integrated Service Network 12
Awardee
Shorla Oncology Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Shorla Oncology Inc., a foreign-owned for-profit organization. The contract is for an interim agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products, with a ceiling value of $25,000.00 and a period of performance ending on August 14, 2024. The contract does not have any set-asides and is a multiple award, meaning...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Agepha Pharma USA LLC, a foreign-owned, self-certified small disadvantaged business and woman-owned small business. The contract, under FSS Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, has a ceiling value of $25,000.00 and a period of performance through June 14, 2024. The purpose of this interim agreement is to provide the VA with access to a variety of pharmaceutical...
This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Pharmaessentia USA Corp, a for-profit organization, on June 1, 2022. The contract has a ceiling value of $6,000,000.00 and a period of performance ending on May 31, 2027. The contract is for the procurement of pharmaceutical and hematology-related products under Federal Supply Schedule 65 IB. As a Federal Supply Schedule contract, it allows for the placement of individual task orders against the...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs, to Sola Pharmaceuticals, LLC. The contract has a period of performance from June 15, 2023 through June 14, 2028, with a ceiling value of $1,500,000.00. The contract is for the provision of "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" under Federal Supply Schedule 65 I B. As a Federal Supply Schedule...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA), provides for the delivery of drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $174,737,620.00 and a period of performance through March 31, 2028. The prime contractor for this multiple award contract is Kowa Pharmaceuticals America Inc., a for-profit manufacturer of goods. The contract does not utilize any set-asides. The scope of the contract encompasses a...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs to Thea Pharma, Inc., a for-profit foreign-owned organization, to provide drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $500,000.00 and a period of performance from February 1, 2023 to January 31, 2028. As a Federal Supply Schedule contract, it is a multiple-award vehicle with no set-asides. The purpose of this contract is to enable federal agencies, primarily...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Springworks Therapeutics, Inc. for the provision of Drugs, Pharmaceuticals, & Hematology Related Products. The contract has a ceiling value of $300,000.00 and a period of performance from April 15, 2024 to April 14, 2029. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows federal agencies to procure the contracted products and services. The scope of the contract...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Stemline Therapeutics, Inc., provides for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $38,007,730.00 and a period of performance from July 15, 2025 to July 14, 2030. As a Federal Supply Schedule contract, this is a multiple-award vehicle that allows federal agencies to purchase the contracted goods and services. The contract...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...